January 12, 2015
The Canadian Institutes of Health Research (CIHR), in partnership with Genome Canada has awarded CAD 2.3 million to the Canadian Rare Diseases Models and Mechanisms (RDMM) Network to investigate molecular mechanisms of rare diseases. Led by Drs. Phil Hieter, Kym Boycott and Janet Rossant, the RDMM network aims to investigate biological mechanisms underlying rare diseases at the genetic level in model organisms such as yeast, worms, flies, fish, mice to gain insights on rare disease mechanisms. The RDMM Network includes basic science researchers studying gene function in model systems and clinician scientists discovering novel disease genes in Canada.